These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11070840)

  • 21. Rapid determination of cellular resistance-related drug efflux in tumor cells.
    Krishan A
    Methods Cell Biol; 1994; 42 Pt B():21-30. PubMed ID: 7877502
    [No Abstract]   [Full Text] [Related]  

  • 22. Heterogeneity of anthracycline retention and response to efflux blockers in human tumors.
    Krishan A
    Cytometry; 1995 Sep; 21(1):72-5. PubMed ID: 8529475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents.
    Quesada AR; Barbacid MM; Mira E; Aracil M; Márquez G
    Cancer Lett; 1996 Jan; 99(1):109-14. PubMed ID: 8564921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
    Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
    J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW
    J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by AV200, a new ardeemin derivative.
    Méndez-Vidal C; Quesada AR
    Cancer Lett; 1998 Oct; 132(1-2):45-50. PubMed ID: 10397452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance.
    Abulrob AN; Mason M; Bryce R; Gumbleton M
    J Drug Target; 2000; 8(4):247-56. PubMed ID: 11144235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug conjugate of doxorubicin with glutathione is a potent reverser of multidrug resistance in rat hepatoma cells.
    Asakura T; Takahashi N; Takada K; Inoue T; Ohkawa K
    Anticancer Drugs; 1997 Feb; 8(2):199-203. PubMed ID: 9073316
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased toxicity of anthracycline antibiotics induced by calcium entry blockers in cultured cardiomyocytes.
    Santostasi G; Kutty RK; Krishna G
    Toxicol Appl Pharmacol; 1991 Mar; 108(1):140-9. PubMed ID: 2006501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative in vitro evaluation of dithiane analogs of tiapamil, Ro 11-2933, Ro 44-5911 and Ro 44-5912 as multidrug resistance modulators.
    Abderrabi M; Marchal S; Merlin JL
    Anticancer Drugs; 1996 Jun; 7(4):430-6. PubMed ID: 8826612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flow cytometric assessment of the cellular pharmacokinetics of fluorescent drugs.
    Dordal MS; Ho AC; Jackson-Stone M; Fu YF; Goolsby CL; Winter JN
    Cytometry; 1995 Aug; 20(4):307-14. PubMed ID: 7587718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3,5-diacetyl-1,4-dihydropyridines: synthesis and MDR reversal in tumor cells.
    Shah A; Gaveriya H; Motohashi N; Kawase M; Saito S; Sakagami H; Satoh K; Tada Y; Solymosi A; Walfard K; Molnar J
    Anticancer Res; 2000; 20(1A):373-7. PubMed ID: 10769682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zosuquidar and an albumin-binding prodrug of zosuquidar reverse multidrug resistance in breast cancer cells of doxorubicin and an albumin-binding prodrug of doxorubicin.
    Abu Ajaj K; Graeser R; Kratz F
    Breast Cancer Res Treat; 2012 Jul; 134(1):117-29. PubMed ID: 22228402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative study of the drug efflux kinetics from sensitive and MDR human breast cancer cells.
    Zhou C; Shen P; Cheng Y
    Biochim Biophys Acta; 2007 Jul; 1770(7):1011-20. PubMed ID: 17451883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new in vivo method to study P-glycoprotein transport in tumors and the blood-brain barrier.
    Hendrikse NH; de Vries EG; Eriks-Fluks L; van der Graaf WT; Hospers GA; Willemsen AT; Vaalburg W; Franssen EJ
    Cancer Res; 1999 May; 59(10):2411-6. PubMed ID: 10344751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.
    Krishan A; Sridhar KS; Mou C; Stein WD; Lyubimov E; Hu YP; Fernandez H
    Clin Cancer Res; 2000 Apr; 6(4):1508-17. PubMed ID: 10778983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
    Mankhetkorn S; Dubru F; Hesschenbrouck J; Fiallo M; Garnier-Suillerot A
    Mol Pharmacol; 1996 Mar; 49(3):532-9. PubMed ID: 8643093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative importance of passive and P-glycoprotein mediated anthracycline efflux from multidrug-resistant cells.
    Wielinga PR; Westerhoff HV; Lankelma J
    Eur J Biochem; 2000 Feb; 267(3):649-57. PubMed ID: 10651800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.